Watson LR, Lew TE, Fox LC, Khot A, et al. Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma. Leuk Lymphoma 2022 Sep 7:1-5. doi: 10.1080/10428194.2022.2118537.
PMID: 36070587